LightningWire Transseptal Puncture System (TPS)— 510(k) K261745

Substantially Equivalent

ElectroWire Medical

FDA 510(k) clearance K261745 for LightningWire Transseptal Puncture System (TPS), Substantially Equivalent on 2026-06-26. Applicant: ElectroWire Medical. Device class: 2.

Summary

ElectroWire Medical's LightningWire Transseptal Puncture System (TPS) is filed under DXF, septostomy catheters. The record doesn't list components or model numbers.

Class II, 21 CFR 870.5175. Cardiovascular is both the classification panel and the review panel, and the submission was a Traditional 510(k).

ElectroWire filed from Lexington, South Carolina. The decision came 30 calendar days after receipt (May 27 to June 26, 2026). The record flags it as a third-party review.

Clearance details

Applicant
ElectroWire Medical
Product code
Product code DXF
Device class
Class 2
Regulation
21 CFR 870.5175
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Lexington, SC, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code DXF

view all

Adverse events under product code DXF

product code DXF
Death
78
Injury
1,126
Malfunction
507
Other
1
Total
1,712

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.